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Abstract
Schistosoma (S.) haematobiumcauses urogenital schistosomiasis and has been hypothe-
sized to adversely impact HIV transmission and progression. On the other hand it has been
hypothesized that HIV could influence the manifestations of schistosomiasis. In this cross-
sectional study, we explored the association between urogenital S. haematobium infection
and CD4 cell counts in 792 female high-school students from randomly selected schools in
rural KwaZulu-Natal, South Africa. We also investigated the association between low CD4
cell counts in HIV positive women and the number of excreted schistosome eggs in urine.
Sixteen percent were HIV positive and 31% had signs of urogenital schistosomiasis (as de-
termined by genital sandy patches and / or abnormal blood vessels on ectocervix / vagina
by colposcopy or presence of eggs in urine). After stratifying for HIV status, participants with
and without urogenital schistosomiasis had similar CD4 cell counts. Furthermore, there was
no significant difference in prevalence of urogenital schistosomiasis in HIV positive women
with low and high CD4 cell counts. There was no significant difference in the number of
eggs excreted in urine when comparing HIV positive and HIV negative women. Our findings
indicate that urogenital schistosomiasis do not influence the number of circulating
CD4 cells.
Introduction
Helminth infections and HIV coexist in areas where the diseases’ burdens are high [1]. Schisto-
soma (S.) haematobium causes urogenital schistosomiasis that has been shown to be associated
with HIV in cross-sectional studies [2–4]. In Sub-Saharan Africa, S. haematobium infection is
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correlated with HIV at a country level [5]. Schistosomiasis has been hypothesized to adversely
impact every phase of HIV / AIDS, e.g. to increase the susceptibility to HIV, influence HIV
viral load and further disease progression [3,6].
It has been proposed that schistosomiasis and other helminths alter the immune system by
skewing it towards a Th2-type response [7]. Chronic helminth infections may therefore pro-
mote HIV-1 pathogenesis [7,8]. Few studies have investigated the effect of helminth infections
on CD4 cell count in HIV negative, and little is known about possible systemic effects of schis-
tosomiasis on the immune system [9]. Furthermore, it has been hypothesized that having a
lower CD4 cell count before HIV seroconversion may accelerate the progression to AIDS [10].
Genital S. haematobium infection in women is characterized by so-called sandy patches that
can appear grainy or homogenous and are thought to be caused by the deposition of schisto-
some eggs in the genital tissues (Fig. 1) [11]. Grainy sandy patches are considered pathogno-
monic for genital schistosomiasis [2]. Sandy patches are often associated with abnormal blood
vessels and contact bleeding due to the fragile mucosa [2].
Fig 1. Sandy patch on the cervix.Colposcopic image of the ectocervix showing a grainy sandy patch at 6 o’clock. In addition there are many scattered
grains in a sector from 4 o’clock to 7 o’clock. Abnormal blood vessels can also be seen on the mucosa, many near and between the schistosome grains.
doi:10.1371/journal.pone.0119326.g001
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However, Schistosoma haematobium is usually explored in urine only [12]. It has been
hypothesized that egg excretion in urine is higher in persons with a functioning immune
system, but the evidence is conflicting [13–15]. In the largest study done on this topic, in
Zimbabwe, Kallestrup et al. did not find decreased egg excretion in participants co-infected
with HIV [13].
To our knowledge, no previous studies have investigated CD4 cell counts in women with
urogenital schistosomiasis.
In this study, we explored the association between urogenital S. haematobium infection and
CD4 cell counts in HIV positive and negative young women. We also investigated the associa-
tion between low CD4 cell counts in HIV positive and the number of excreted schistosome
eggs in urine.
Materials and Methods
Study design and population
This cross-sectional study took place fromMay to October 2013. The participants were part of
a cohort of female high-school students included in a prospective study on female genital schis-
tosomiasis in rural KwaZulu-Natal, South Africa. All women who were sexually active and
above the age of 16 years were invited to participate in the study. CD4 cell counts and HIV test-
ing were done in all study participants seen during this period. Women from 26 randomly se-
lected high schools were included. Pregnant women were not investigated.
This rural district on the East coast is one of the poorest in South Africa, endemic for uro-
genital schistosomiasis and with a high prevalence of HIV [16,17].
Clinical investigation
The gynecological examinations were performed by trained female medical doctors. The entire
cervicovaginal surface was examined colposcopically using an Olympus OCS 500 Colposcope
with a mounted Olympus E420 (10 Mpx) or a Leisegang colposcope with a mounted Canon
EOS 650D (18 Mpx). Lesions indicating genital schistosomiasis were recorded as sandy patches
with or without the presence of abnormal blood vessels [2].
Laboratory analyses
A urine sample was collected between 10 a.m. and 2 p.m. to ensure optimal egg yield [18].
Merthiolate-formalin solution (2%) was added to 10 mL of urine. Urine samples were centri-
fuged and the whole pellet was deposited on one or more glass slides. Schistosome eggs in
urine were counted by microscopy by trained research assistants. The mean egg intensity
(eggs / mL) was calculated by dividing the total number of eggs in a urine sample by the vol-
ume. A positive diagnosis was recorded if at least one egg was seen.
HIV testing was done using Bioline Rapid Test HIV (NJ, US) and confirmatory Sensa Tri-
Line HIV Test Kit (Pantech, Durban, South Africa).
Blood was collected in EDTA tubes for CD4 analyses and serum samples for frozen storage
(Vacutainer tubes, Becton, Dickinson and Company (BD), Franklin Lakes, NJ, US). The EDTA
tubes were transported to the NHLS laboratory, Stanger Hospital, accredited by the SA Nation-
al Accreditation System (SANAS)—an independent legislated body for compliance with inter-
national standards (ISO 15189:2007). CD4 cell count analyses were performed within 24 hours
by a Beckman Coulter flow cytometer (Cytomics FC 500, Brea, California, US).
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Ethical considerations
Research ethical committees in South Africa and Norway approved the study (Biomedical Re-
search Ethics Committee (BREC), University of KwaZulu-Natal (Ref BF029/07), KwaZulu-Natal
Department of Health, (Reference HRKM010–08) and the Regional Committee for Medical and
Health Research Ethics (REC), South Eastern Norway (Ref 469–07066a1.2007.535)). Further-
more, the Departments of Health and Education in Ugu district, KwaZulu-Natal gave permis-
sions for this study. All participants signed individual, written informed consent forms. The
ethical committees, BREC (annual renewal) and REC, were aware that minors were participating
in the study and specifically approved the consent procedure (independent minor consent, no
parental consent). STI treatment was offered in accordance with the South African syndromic
treatment protocol [19]. Anti-schistosomal treatment was offered to all as part of a mass drug ad-
ministration campaign. All participants were tested for HIV, but disclosure of the result was vol-
untary. HIV testing and follow-up was done in accordance with South African guidelines with
pre- and post-test counseling. If the CD4 cell count was below 350 x 106 cells / L, the patient was
contacted by an HIV counselor, and taken to her local clinic for follow-up according to official
South African guidelines. HIV negative women with a CD4 cell count below 350 x 106 cells / L
were asked to come for repeat tests for both HIV and CD4 cell count. HIV positive patients were
referred to local clinics for follow-up and treatment. South Africa provides universal access to an-
tiretroviral treatment (ARV).
Statistical analyses
Statistical analyses were performed using IBM SPSS Statistics version 20 (Armonk, NY, USA).
Sample size calculation showed that in a population with 20% urogenital schistosomiasis
(assumed prevalence), we needed to recruit 600 participants in order to detect a difference in
mean CD4 cell count of 80 x 106 cells / L with a power of 80% [20]. A 95% interval of confi-
dence was used throughout.
The CD4 cell counts followed a close to normal distribution. Stratifying for HIV status, we
used the Student’s t-test to compare mean CD4 cell counts for women with and without sandy
patches, abnormal blood vessels and schistosome eggs in urine.
In HIV positive women, we defined three groups by CD4 cell count (below 350, 350–500 and
above 500 x 106 cells / L). We used analysis of variance (ANOVA) when comparing these groups’
prevalences of sandy patches, abnormal blood vessels and schistosome eggs in urine. Egg counts
were log transformed in order to obtain normal distribution. Linear regression was used when in-
vestigating the association between mean egg intensity in urine and CD4 cell count.
Results
CD4 cell counts were performed in 792 students from 26 rural high schools. The mean age was
18.9 years (standard deviation (SD) 2.2). We obtained HIV tests from 765, of which 123 were
HIV positive (16.1%). The mean age for HIV positive women was 20.1 (SD 2.4) years as op-
posed to 18.7 (SD 2.1) years for the HIV negative. Only 30.1% of the HIV positive (37/123) re-
ported that they knew they were HIV positive, and 54.1% of these (20/37) reported to be on
ARVs. As expected, the HIV negative group had a significantly higher mean CD4 cell count
than the HIV positive group (931 [SD 289, range 236–2549] vs. 512 [SD 243, range 60–1359] x
106 cells / L, p< 0.001).
The clinicians reported genital sandy patches in 78 women (12.2%) and abnormal blood
vessels in 294 women (45.8%). We found schistosome eggs in urine samples from 154 partici-
pants (20.0%). In total, 208 of 665 women (31.3%) had either sandy patches or S. haematobium
eggs in urine.
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Genital lesions, urinary schistosomiasis and CD4 cell count
There was no significant difference in CD4 cell counts between the participants with and with-
out sandy patches, abnormal blood vessels or schistosome eggs in urine after stratifying for
HIV status (Fig. 2). Also after combining the findings of genital sandy patches and / or eggs in
urine, we found no difference in mean CD4 cell count (Fig. 2).
Schistosomiasis prevalence and low CD4 cell count
The prevalences of sandy patches, abnormal blood vessels and schistosome eggs in urine in
HIV positive women were similar across three groups defined by CD4 cell count (below 350,
350–500 and above 500 x 106 cells / L). The results are presented in Fig. 3.
Schistosoma egg excretion (intensity) and CD4 cell count
In women with schistosome eggs in urine, there was no significant difference in mean egg ex-
cretion between the HIV positive and HIV negative (12.3 and 10.9 eggs / 10 mL, respectively,
p = 0.760). Furthermore, we did not find any significant difference in mean egg excretion in
HIV positive across the three groups defined by CD4 cell count (Fig. 3). In a regression analysis
Fig 2. Genital lesions, urinary schistosomiasis and CD4. Boxplots showing CD4 cell counts in HIV negative and positive women with different findings of
urogenital schistosomiasis. The whiskers represent the 10th and 90th percentiles. The mean CD4 cell counts showed no significant differences between any
of the groups.
doi:10.1371/journal.pone.0119326.g002
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including participants excreting eggs, there was no significant linear association between egg ex-
cretion and CD4 cell count in HIV negative or positive women (r2 = 0.002 and 0.001, p = 0.665
and p = 0.869, respectively, Fig. 4).
Discussion
In this study, we did not find a significant difference in mean CD4 cell count of women with
and without urogenital schistosomiasis (genital lesions and / or urinary schistosomiasis), nei-
ther in the HIV negative nor positive group. Further, we did not find a significant difference in
urine S. haematobium egg intensities when comparing HIV positive women with low and high
CD4 cell counts.
CD4 cell counts are rarely explored in HIV negative individuals, and this was the first study
to explore the effects of S. haematobium on CD4 cell count comprehensively [21–24]. It may
be surprising that there was no significant difference in CD4 cell count between women with
and without urogenital schistosomiasis, as the infection causes systemic pathological effects
[9]. However, studies on the effects of helminths on CD4 levels have shown various results
[21,23–25]. An Ethiopian study did not find any association between intestinal parasitic infec-
tions and CD4 cell count [26]. Likewise, a Ugandan study of HIV infected persons did not find
lower CD4 cell counts in those co-infected with S.mansoni [23]. Furthermore, anthelminthic
therapy did not show any significant impact on the CD4 cell count [23]. However, Kallestrup
et al. included both HIV positive and negative persons to a randomized controlled trial, and
found that praziquantel treatment was associated with a slight increase in CD4 cell count in
HIV positive women [21]. A Cochrane analysis on the treatment of HIV positive with helminth
co-infection concluded that anti-helminthic treatment may slow the decline in CD4 cell count
[27]. However, a review including observational data did not find that treating helminth infec-
tions improved the CD4 cell count [28].
Fig 3. Urogenital schistosomiasis and CD4 in HIV positive. HIV positive women were grouped by CD4 cell count (< 350, 350–500 and> 500 x 106 cells /
L). Mean prevalence of findings related to urogenital schistosomiasis was compared across the groups using analysis of variance (ANOVA). The resulting p-
value is indicated above each group. Error bars represent 95% confidence intervals. No significant difference was found for any variable across the
CD4 groups.
doi:10.1371/journal.pone.0119326.g003
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Our findings indicate that the mean CD4 cell count in women was not influenced by schis-
tosomiasis or that the level of egg excretion was influenced by CD4 cell count. There were few
adult survivors of mother-to-child transmission of HIV at the time of the study, and relatively
recent sexual transmission was most likely in this young population. This may be the reason
we had few subjects with very low CD4 cell counts, and none below 50 x 106 cells / L. The find-
ings might therefore represent a Type 2 error due to a limited sample size or sub-optimal sensi-
tivity and specificity of the investigations. Several clinicians investigated women, and we
cannot rule out the possibility of inter-observer variability in the colposcopic examinations. A
computer image analysis of lesions may improve the FGS diagnosis (Holmen et al., submitted).
Stool samples were not investigated in our study and hence we were not able to assess the
possible effects of soil-transmitted helminths on the CD4 cell count. Sexually transmitted infec-
tions, such as syphilis, may also influence the CD4 cell count [29]. S.mansoni was not likely to
be a confounder, since only very scanty pockets of this species are found in this area of South
Africa. We only collected one urine sample and the intensity of infection (mean egg count) and
the prevalence of S. haematobiummight be higher [30]. A more sensitive test, such as circulat-
ing anodic antigen (CAA), would have given an indication of the number of women with live
schistosomiasis worms [31]. Helminth infections are often present in the host for years and
regulate the immune system, but effects may be subtle and vary between helminth species
[32,33]. Increased numbers of HIV target cells have been found to be associated with genital
Fig 4. Egg excretion and CD4. Scatterplot showing CD4 cell counts and urine schistosome egg intensity in HIV negative and positive women. Only women
excreting schistosome eggs (n = 156) were included. Regression lines were fitted for each of the groups. No linear associations were found.
doi:10.1371/journal.pone.0119326.g004
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schistosomiasis in cervical samples, and these local immune responses may be of greater im-
portance to the susceptibility to HIV than the systemic effects [34,35]. It is also possible that S.
haematobium infection affects the proportions of CD4 T-cell sub-populations [36] without
changing the CD4 cell count significantly.
In one study of HIV positive individuals, several parasitic infections occurred more fre-
quently in those with low CD4 cell counts, as is the case with opportunistic infections [37]. But
it has also been hypothesized that chronic parasitic infections themselves shift the T-cell popu-
lations and decrease the CD4+ cell count [24,33]. Immune deficiency may influence egg excre-
tion, but the evidence is conflicting [13–15]. We did not find any indication of lower egg
excretion in the urine of HIV positive women, even with low CD4 cell counts. Furthermore, we
found similar numbers of genital lesions in women with low CD4 cell counts. The described as-
sociation between HIV and urogenital schistosomiasis [3,4] was therefore not likely to be influ-
enced by altered egg excretion in HIV positive. Further studies are warranted to rule out
whether severe immunodeficiency may influence egg excretion in urine and / or the appear-
ance of genital lesions.
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